Validation of a diagnostic score model for the prediction of Legionella pneumophila pneumonia

被引:27
作者
Miyashita, Naoyuki [1 ]
Horita, Nobuyuki [2 ]
Higa, Futoshi [3 ]
Aoki, Yosuke [4 ]
Kikuchi, Toshiaki [5 ]
Seki, Masafumi [6 ]
Tateda, Kazuhiro [7 ]
Maki, Nobuko [8 ]
Uchino, Kazuhiro [9 ]
Ogasawara, Kazuhiko [1 ]
Kiyota, Hiroshi [10 ]
Watanabe, Akira [11 ]
机构
[1] Kansai Med Univ, Div Resp Med Infect Dis & Allergol, Dept Internal Med 1, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Pulmonol, Yokohama, Japan
[3] Natl Hosp Org Okinawa Natl Hosp, Ginowan, Okinawa, Japan
[4] Saga Univ Hosp, Dept Infect Dis & Hosp Epidemiol, Saga, Japan
[5] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, Niigata, Japan
[6] Tohoku Med & Pharmaceut Univ Hosp, Div Infect Dis & Infect Control, Sendai, Miyagi, Japan
[7] Toho Univ, Sch Med, Dept Microbiol & Infect Dis, Ota City, Tokyo, Japan
[8] Taisho Toyama Pharmaceut Co Ltd, Tokyo, Japan
[9] Daiichi Sankyo Co Ltd, Tokyo, Japan
[10] Jikei Univ, Katsushika Med Ctr, Dept Urol, Tokyo, Japan
[11] Tohoku Bunka Gakuen Univ, Fac Med Sci & Welf, Dev Antiinfect Agents, Sendai, Miyagi, Japan
基金
日本学术振兴会;
关键词
Community-acquired pneumonia; C-reactive protein; Diagnostic score; Legionella pneumophila; Serum sodium; COMMUNITY-ACQUIRED PNEUMONIA; LEGIONNAIRES-DISEASE; CLINICAL-DIAGNOSIS; ETIOLOGY; SEVERITY; SEROGROUPS; PATHOGENS; CRITERIA; IMPACT; AGE;
D O I
10.1016/j.jiac.2019.03.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Community-acquired pneumonia (CAP) due to Legionella has a high mortality rate in patients who do not receive adequate antibiotic therapy. In a previous study, we developed a simple Legionella Score to distinguish patients with Legionella and non-Legionella pneumonia based on clinical information at diagnosis. In the present study, we validated this Legionella Score for the presumptive diagnosis of Legionella CAP. Methods: This validation cohort included 109 patients with Legionella CAP and 683 patients with non-Legionella CAP. The Legionella Score includes six parameters by assigning one point for each of the following items: being male, absence of cough, dyspnea, C-reactive protein (CRP) >= 18 mg/dL, lactate dehydrogenase (LDH) >= 260 U/L, and sodium < 134 mmol/L. Results: When the Legionella CAP and non-Legionella CAP were compared by univariate analysis, most of the evaluated symptoms and laboratory test results differed substantially. The six parameters that were used for the Legionella Score also indicated clear differences between the Legionella and non-Legionella CAP. All Legionella patients had a score of 2 points or higher. The median Legionella Scores were 4 in the Legionella CAP cases and 2 in the non-Legionella CAP cases. A receiver operating characteristics curve showed that the area under the curve was 0.93. The proposed best cutoff, total score >= 3, had sensitivity of 93% and specificity of 75%. Conclusion: Our Legionella Score was shown to have good diagnostic ability with a positive likelihood of 3.7 and a negative likelihood of 0.10. (c) 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [31] Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia
    Grau, Santiago
    Mateu-de Antonio, Javier
    Ribes, Esther
    Savado, Margarita
    Garces, Jose Maria
    Garau, Javier
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (03) : 249 - 252
  • [32] Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis
    Garcia-Vidal, C.
    Sanchez-Rodriguez, I.
    Simonetti, A. F.
    Burgos, J.
    Viasus, D.
    Martin, M. T.
    Falco, V.
    Carratala, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (09) : 653 - 658
  • [33] In vivo effect of adhesion inhibitor heparin on Legionella pneumophila pathogenesis in a murine pneumonia model
    Florence Ader
    Rozenn Le Berre
    Rémi Fackeure
    Dominique Raze
    Franco Dante Menozzi
    Nathalie Viget
    Karine Faure
    Eric Kipnis
    Benoît Guery
    Sophie Jarraud
    Jerome Etienne
    Christian Chidiac
    Intensive Care Medicine, 2008, 34 : 1511 - 1519
  • [34] Severe pneumonia caused by Legionella pneumophila detected by a multiplex polymerase chain reaction assay and confirmed by serology
    Jovanovic, Milica
    Mitrovic, Nikola
    Beraud, Letitia
    Trboljevac, Nikola
    Milosevic, Branko
    Radovanovic Spurnic, Aleksandra
    Jovanovic, Snezana
    Maric, Dragana
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [35] Endogenous lipoid pneumonia associated with Legionella pneumophila serogroup 1
    Hui, Chee-Kin
    SINGAPORE MEDICAL JOURNAL, 2013, 54 (03) : E66 - E67
  • [36] Legionella pneumophila community acquired pneumonia (CAP) presenting with myoclonus
    Cunha, Burke A.
    Syed, Uzma
    JOURNAL OF INFECTION, 2010, 61 (06) : 505 - 507
  • [37] Community acquired pneumonia by Legionella pneumophila: Study of 136 cases
    Romay-Lema, Eva
    Corredoira-Sanchez, Juan
    Ventura-Valcarcel, Pablo
    Iniguez-Vazquez, Iria
    Garcia Pais, Maria-Jose
    Garcia-Garrote, Fernando
    Rabunal Rey, Ramon
    MEDICINA CLINICA, 2018, 151 (07): : 265 - 269
  • [38] TOLLIP deficiency is associated with increased resistance to Legionella pneumophila pneumonia
    Shah, Javeed A.
    Emery, Robyn
    Lee, Brian
    Venkatasubramanian, Sambasivan
    Simmons, Jason D.
    Brown, Melanie
    Hung, Chi F.
    Prins, Jan M.
    Verbon, Annelies
    Hawn, Thomas R.
    Skerrett, Shawn J.
    MUCOSAL IMMUNOLOGY, 2019, 12 (06) : 1382 - 1390
  • [39] Typical Presentation of Legionella pneumophila Community-Acquired Pneumonia
    Cilloniz, C.
    Torres, A.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2017, 23 (03) : 115 - 116
  • [40] Multiplex PCR for the simultaneous detection of Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila in community-acquired pneumonia
    Miyashita, N
    Saito, A
    Kohno, S
    Yamaguchi, K
    Watanabe, A
    Oda, H
    Kazuyama, Y
    Matsushima, T
    RESPIRATORY MEDICINE, 2004, 98 (06) : 542 - 550